| Similar Articles |
|---|
 |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV.   |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
Nursing
August 2008
Carl A. Kirton |
Managing Long-Term Complications of HIV Infection Now that advances in treatment have transformed HIV into a chronic, manageable disease, patients are facing cardiovascular and metabolic complications you might not have expected 15 years ago. Here's how to help your patient manage them. |
American Family Physician
July 15, 2004
Joel E. Gallant |
HIV Counseling, Testing, and Referral By the year 2005, the CDC seeks to achieve the following: reduce annual new HIV infections from the current estimated 40,000 cases to 20,000 cases through the use of interventions such as counseling, HIV testing, and referral |
American Family Physician
August 1, 2000
Sharon Scott Morey |
Practice Guidelines HHS Updates Guidelines for Antiretroviral Therapy in HIV Infection |
American Family Physician
January 15, 2006
Ann M. Khalsa |
Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection The epidemic of HIV continues, and the infection is converting into a treatable chronic disease; therefore, it is increasingly important for family physicians to be current with and comfortable in providing basic care to patients infected with HIV. |
Pharmaceutical Executive
December 1, 2005
Alana Klein |
Thought Leader: A Q&A with Graham Allaway While researchers continue to hunt for new AIDS drugs, Graham Allaway, chief operating officer of Panacos Pharmaceuticals, is focusing on developing a treatment for patients failing therapy due to resistance. |
American Family Physician
July 15, 2004
Robertson & Montagnini |
Geriatric Failure to Thrive Some elderly patients, including those who do not have acute illness or severe chronic disease, eventually undergo a process of functional decline, progressive apathy, and a loss of willingness to eat and drink that culminates in death. |
Nurse Practitioner
August 2011
Davis et al. |
Supportive approaches for Alzheimer Disease Alzheimer disease accounts for almost 80% of all dementia diagnoses. Currently, more than 5 million Americans suffer from this debilitating illness, with the highest prevalence in the oldest age groups. |
American Journal of Nursing
November 2011
Christine L. Cutugno |
The 'Graying' of Trauma Care: Addressing Traumatic Injury in Older Adults Evidence-based strategies for managing trauma and its complications in this population. |
American Family Physician
May 15, 2002
Alex H. Krist & Amy Crawford-Faucher |
Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues... |
American Family Physician
February 1, 2001
Eleftherios Mylonakis |
Plasma Viral Load Testing in the Management of HIV Infection In the 1990s, new technologies, including the polymerase chain reaction assay, the branched DNA assay and the nucleic acid sequence-based amplification assay, made it possible to obtain accurate quantitative measurements of human immunodeficiency virus (HIV) RNA in plasma... |
Popular Mechanics
December 1, 2006
Ben Harder |
Fighting HIV by Building a New Killer In the fight to find a cure for AIDS, researchers have invented a viral double agent on a mission to seek out where HIV hides. |
Salon.com
July 17, 2000
Nina Teicholz |
When drugs take a holiday Could taking a break from protease inhibitors be the secret to treating AIDS? A new case of a 40-year-old man in Philadelphia shows it's possible. |
American Family Physician
November 15, 2002
Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
American Family Physician
December 1, 2000
Monica Preboth |
Clinical Briefs HIV Testing for Children in Foster Care... Nutrition Guidelines for Patients on Dialysis... Exercise and Health in the Older Adult... Intervention Strategies and Treatment of Substance Abuse Problems... |
American Family Physician
May 15, 2002 |
HIV: Coping with the Diagnosis I'm scared. How can I cope with my fear?... What can I do to help myself?... Who should know I have HIV?... What legal issues should I consider?... |
Nursing
August 2010
Bartley & Shiflett |
Handle older trauma patients with care Your comprehensive understanding of how age-related changes can affect outcomes during and after trauma will help your patients recover to the fullest extent possible. |
American Family Physician
May 1, 2004
Daniel Knight |
Health Care Screening for Men Who Have Sex with Men Recommendations on health care screenings for men who have sex with men, who are at increased risk for STDs such as HIV infection, anal cancer, and psychologic and behavioral disorders. |
Pharmaceutical Executive
July 30, 2007
Walter Armstrong |
Tibotec Gets AIDS With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, Tibotec is in it to win it. And end it. |
The Motley Fool
July 13, 2004
Charly Travers |
With Pfizer Drug, HIV Retreats Pfizer's newest HIV treatment shows promise in a demanding market. |
American Family Physician
August 15, 2003
Lesho & Gey |
Managing Issues Related to Antiretroviral Therapy HIV-related deaths and opportunistic infections have decreased dramatically since the advent of highly active antiretroviral therapy, and health care providers are focusing on management of increasingly complex drug regimens and their associated interactions and toxicities. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
American Family Physician
January 1, 2001
Alex H. Krist |
Obstetric Care in Patients with HIV Disease Appropriate management of pregnant patients who have human immunodeficiency virus (HIV) disease can have a major impact on maternal and infant health... |
Salon.com
May 8, 2001
Daryl Lindsey |
The "Joe Camel" ads of AIDS? The FDA says ads for drugs to suppress HIV are making false promises, and could be contributing to an epidemic of unsafe sex... |
Nursing
March 2010
Peg Gray-Vickrey |
Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice. |
The Motley Fool
April 3, 2008
Brian Lawler |
A Punch to Gilead's Competition A rival compound's bad data signals a better future for Gilead's lead drugs. |
Scientific American
October 2008
John Rennie |
Hope and the Fight against HIV The battle must continue, even if 25 years of research have disappointed. |
Nursing
July 2008
Daniel A. Hussar |
New Drugs08, Part 2 Here, you'll learn about eight new drugs, including doripenem, maraviroc and ixabepilone. |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk. |
BusinessWeek
March 26, 2009
Aili McConnon |
Gilead Sciences: High-Performing Pharmaceutical Gilead owes much of its success to making it easier for patients to comply with complex and uncomfortable drug regimens. |
Nurse Practitioner
May 2008
Jarosz & Bellar |
Age-Appropriate Obesity Treatment Older adults who are obese must be assessed and treated for obesity within the context of aging. |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
American Family Physician
July 15, 2001
Sweeney & Neff |
Newsletter HHS Releases a Clinical Guide on the Treatment of Women with HIV... CSAT Offers Grants for Rural Drug Treatment Centers... Federal Agencies Mark 20th Anniversary of First AIDS Case... New Web Site Provides Information on Food-borne Illnesses... NIH Establishes National Family Registry for Scleroderma... |
American Family Physician
May 15, 2002 |
HIV in Women What are HIV and AIDS?... How do women become infected with HIV?... Is HIV infection different in women and men?... What precautions can be taken to avoid getting HIV during sex?... What should I do if I think I may be infected?... |
American Family Physician
July 15, 2004 |
HIV Infection - How to Lower Your Risk A consumer-oriented brochure discussing the many ways to lower the risk of getting human immunodeficiency virus (HIV) infection and where to go for help. |
The Motley Fool
November 27, 2009
Brian Orelli |
A Mostly Meaningless FDA Approval After an accelerated approval, the positive effects of a full approval are minimal for Johnson & Johnson's drug, Intelence. |
The Motley Fool
December 21, 2004
Brian Gorman |
Bristol-Myers, Gilead Team Up The drugmakers' alliance will benefit both the companies and HIV patients. |
Fast Company
August 8, 2011
Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
The Motley Fool
January 21, 2010
Brian Orelli |
Here's That Critical Merck Info You Missed Announcing clinical trial failures in a FAQ? Really? |
American Family Physician
January 1, 2001 |
HIV Infection and Pregnancy-Protecting Your Baby and Yourself Why should I be tested for HIV if I am pregnant?... How do babies get HIV?... What can I do to keep my baby from getting HIV?... What antiretroviral medicines should I be taking?... Should I have an elective cesarean section?... |
BusinessWeek
September 2, 2010
Simeon Bennett |
David Margolis' Fight to End AIDS The North Carolina professor is relying on Zolinza, a rarely used Merck cancer drug, to stamp out AIDS. |
American Family Physician
May 1, 2005
Adelman & Daly |
Initial Evaluation of the Patient with Suspected Dementia It is common for older patients to present to family physicians with concerns of memory loss. With an accurate and timely diagnosis of dementia, appropriate therapies can be initiated to reduce further cognitive decline. |
BusinessWeek
February 10, 2011
Rob Waters |
Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology. |
The Motley Fool
September 29, 2011
Brian Orelli |
Are HIV Drugmakers Doomed? Generics are a bigger threat than Sangamo for now. |
Bio-IT World
November 14, 2003
John Dodge |
Pfizer's Man with the R&D Plan As Pfizer senior vice president, science and technology, Peter B. Corr oversees $7.1 billion in annual research and development spending, the biggest private R&D budget in the world. In this interview, Corr talks about IT, clinical trials, and his $7-billion budget. |
Salon.com
December 1, 2000
Fiona Morgan |
It's World AIDS Day ... again Americans with insurance now improve with new drugs, but the disease is on a rampage across the rest of the world... |
The Motley Fool
December 14, 2006
Stephen Albainy-Jenei |
Merck Gets Punk'd by Thailand Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug. This is an act of humanitarian aid, but it is also an avenue for price and profit erosion worldwide. |
BusinessWeek
February 19, 2007
Arlene Weintraub |
How Gilead Primed The Pipeline Gilead's $2.5 billion purchase of Myogen offers instant diversification from its HIV drug focus. |
